Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study
Abstract Background Pathological complete response (pCR) is the goal of neoadjuvant chemotherapy (NACT). We aimed to develop a nomogram to predict the probability of achieving pCR in estrogen receptor-positive (ER+), HER2-negative (HER2−) breast cancer patients. Methods A total of 273 ER+, HER2− bre...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2022-01-01
|
| סדרה: | World Journal of Surgical Oncology |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12957-022-02492-7 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|